Measuring the Quality of Palliative Care for Patients with End-Stage Liver Disease.
Cirrhosis
End of life
Healthcare quality
Palliative care
Veterans
Journal
Digestive diseases and sciences
ISSN: 1573-2568
Titre abrégé: Dig Dis Sci
Pays: United States
ID NLM: 7902782
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
received:
09
08
2019
accepted:
27
11
2019
pubmed:
14
1
2020
medline:
30
12
2020
entrez:
14
1
2020
Statut:
ppublish
Résumé
We examined the quality of palliative care received by patients with decompensated cirrhosis using an explicit set of palliative care quality indicators (QIs) for patients with end-stage liver disease (PC-ESLD). We identified patients newly diagnosed with decompensated cirrhosis at a single veterans health center and followed up them for 2 years or until death. We piloted measurement of PC-ESLD QIs in all patients confirmed to have ESLD using a chart abstraction tool. Out of 167 patients identified using at least one sampling strategy, 62 were confirmed to meet ESLD criteria with chart abstraction. Ninety-eight percent of veterans in the cohort were male, mean age at diagnosis was 61 years, and 74% were White. The overall QI pass rate was 68% (64% for information care planning QIs and 76% for supportive care QIs). Patients receiving specialty palliative care consultation were more likely to receive information care planning QIs (67% vs. 37%, p = 0.02). The best performing sampling strategy had a sensitivity of 62% and specificity of 60%. Measuring the quality of palliative care for patients with ESLD is feasible in the veteran population. Our single-center data suggest that the quality of palliative care is inadequate in the veteran population with ESLD, though patients offered specialty palliative care consultation and those affected by homelessness, drug, and alcohol abuse may receive better care. Our combination of ICD-9 codes can be used to identify a cohort of patients with ESLD, though better sensitivity and specificity may be needed.
Sections du résumé
BACKGROUND/AIMS
We examined the quality of palliative care received by patients with decompensated cirrhosis using an explicit set of palliative care quality indicators (QIs) for patients with end-stage liver disease (PC-ESLD).
METHODS
We identified patients newly diagnosed with decompensated cirrhosis at a single veterans health center and followed up them for 2 years or until death. We piloted measurement of PC-ESLD QIs in all patients confirmed to have ESLD using a chart abstraction tool.
RESULTS
Out of 167 patients identified using at least one sampling strategy, 62 were confirmed to meet ESLD criteria with chart abstraction. Ninety-eight percent of veterans in the cohort were male, mean age at diagnosis was 61 years, and 74% were White. The overall QI pass rate was 68% (64% for information care planning QIs and 76% for supportive care QIs). Patients receiving specialty palliative care consultation were more likely to receive information care planning QIs (67% vs. 37%, p = 0.02). The best performing sampling strategy had a sensitivity of 62% and specificity of 60%.
CONCLUSION
Measuring the quality of palliative care for patients with ESLD is feasible in the veteran population. Our single-center data suggest that the quality of palliative care is inadequate in the veteran population with ESLD, though patients offered specialty palliative care consultation and those affected by homelessness, drug, and alcohol abuse may receive better care. Our combination of ICD-9 codes can be used to identify a cohort of patients with ESLD, though better sensitivity and specificity may be needed.
Identifiants
pubmed: 31927765
doi: 10.1007/s10620-019-05983-y
pii: 10.1007/s10620-019-05983-y
pmc: PMC7223418
doi:
Types de publication
Comparative Study
Journal Article
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
2562-2570Subventions
Organisme : U.S. Department of Veterans Affairs
ID : 121 HX001804
Pays : International
Organisme : NIMH NIH HHS
ID : T32 MH019200
Pays : United States
Références
Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464–470.
doi: 10.1053/jhep.2001.22172
D’Amico G, Morabito A, Pagliaro L, et al. Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci. 1986;31:468–475. https://doi.org/10.1007/BF01320309 .
doi: 10.1007/BF01320309
pubmed: 3009109
Kim WR, Lake JR, Smith JM, et al. OPTN/SRTR 2015 Annual Data Report: Liver. Am J Transplant. 2017;17:174–251.
doi: 10.1111/ajt.14126
Murphy SL, X., Kochanek KD. Deaths: final data for 2010. Updated May 8, 2013. Centers for Disease Control and Prevention website.
Rakoski MO, McCammon RJ, Piette JD, et al. Burden of cirrhosis on older Americans and their families: analysis of the health and retirement study. Hepatology. 2012;55:184–191.
doi: 10.1002/hep.24616
Roth K, Lynn J, Zhong Z, et al. Dying with end stage liver disease with cirrhosis: insights from SUPPORT. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. J Am Geriatr Soc. 2000;48:S122-30.
pubmed: 10809465
Brown CL, Hammill BG, Qualls LG, et al. Significant morbidity and mortality among hospitalized end-stage liver disease patients in medicare. J Pain Symptom Manage. 2016;52:412–419.
doi: 10.1016/j.jpainsymman.2016.03.013
Patel AA, Walling AM, Ricks-Oddie J, et al. Palliative care and health care utilization for patients with end-stage liver disease at the end of life. Clin Gastroenterol Hepatol. 2017;15:1612–1619.
doi: 10.1016/j.cgh.2017.01.030
Smith TJ, Temin S, Alesi ER, et al. American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol. 2012;30:880–887.
doi: 10.1200/JCO.2011.38.5161
Hunt SA. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005;112:e154–e235.
pubmed: 16160202
Lanken PN, Terry PB, DeLisser HM, et al. An official American Thoracic Society clinical policy statement: palliative care for patients with respiratory diseases and critical illnesses. Am J Respir Crit Care Med. 2008;177:912–927.
doi: 10.1164/rccm.200605-587ST
Galla JH. Clinical practice guideline on shared decision-making in the appropriate initiation of and withdrawal from dialysis: The Renal Physicians Association and the American Society of Nephrology. J Am Soc Nephrol. 2000;11:1340–1342.
pubmed: 10864592
Walling AM, Ahluwalia SC, Wenger NS, et al. Palliative care quality indicators for patients with end-stage liver disease due to cirrhosis. Dig Dis Sci. 2017;62:84–92. https://doi.org/10.1007/s10620-016-4339-3 .
doi: 10.1007/s10620-016-4339-3
pubmed: 27804005
Yee HS, Chang MF, Pocha C, et al. Update on the management and treatment of hepatitis C virus infection: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program Office. Am J Gastroenterol. 2012;107:669–689.
doi: 10.1038/ajg.2012.48
Kanwal F, Hoang T, Kramer JR, et al. Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection. Gastroenterology. 2011;140:1182–1188.
doi: 10.1053/j.gastro.2010.12.032
Julapalli VR, Kramer JR, El‐Serag HB, et al. Evaluation for liver transplantation: adherence to AASLD referral guidelines in a large Veterans Affairs center. Liver Transpl. 2005;11:1370–1378.
doi: 10.1002/lt.20434
Goldberg D, Lewis D, Halpern SD, et al. Validation of three coding algorithms to identify patients with end-stage liver disease in an administrative database. Pharmacoepidemiol Drug Saf. 2012;21:765–769.
doi: 10.1002/pds.3290
Lo Re V III, Lim JK, Goetz MB, et al. Validity of diagnostic codes and liver-related laboratory abnormalities to identify hepatic decompensation events in the Veterans Aging Cohort Study. Pharmacoepidemiol Drug Saf. 2011;20:689–699.
doi: 10.1002/pds.2148
Clopper CJ, Pearson ES. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika. 1934;26:404–413.
doi: 10.1093/biomet/26.4.404
Cholongitas E, Papatheodoridis GV, Vangeli M, et al. Systematic review: The model for end-stage liver disease–should it replace Child-Pugh’s classification for assessing prognosis in cirrhosis? Aliment Pharmacol Ther. 2005;22:1079–1089.
doi: 10.1111/j.1365-2036.2005.02691.x
Walling AM, Asch SM, Lorenz KA, et al. The quality of care provided to hospitalized patients at the end of life. Arch Intern Med. 2010;170:1057–1063.
doi: 10.1001/archinternmed.2010.175
Brisebois A, Ismond KP, Carbonneau M, et al. Advance care planning (ACP) for specialists managing cirrhosis: a focus on patient-centered care. Hepatology. 2018;67:2025–2040.
doi: 10.1002/hep.29731
D’Ambruoso SF, Coscarelli A, Hurvitz S, et al. Use of a shared mental model by a team composed of oncology, palliative care, and supportive care clinicians to facilitate shared decision making in a patient with advanced cancer. J Oncol Pract. 2016;12:1039–1045.
doi: 10.1200/JOP.2016.013722
Baumann AJ, Wheeler DS, James M, et al. Benefit of early palliative care intervention in end-stage liver disease patients awaiting liver transplantation. J Pain Symptom Manage. 2015;50:882–886.
doi: 10.1016/j.jpainsymman.2015.07.014
Walling AM, Tisnado D, Asch SM, et al. The quality of supportive cancer care in the veterans affairs health system and targets for improvement. JAMA Intern Med. 2013;173:2071–2079.
doi: 10.1001/jamainternmed.2013.10797
Thomson MJ, Tapper EB, Lok ASF. Dos and don’ts in the management of cirrhosis: a view from the 21st century. Am J Gastroenterol. 2018;113:927.
doi: 10.1038/s41395-018-0028-5
Chandok N, Watt KD. Pain management in the cirrhotic patient: the clinical challenge. Mayo Clin Proc. 2010;85:451–458.
doi: 10.4065/mcp.2009.0534
Ahmed N, Bestall JE, Ahmedzai SH, et al. Systematic review of the problems and issues of accessing specialist palliative care by patients, carers and health and social care professionals. Palliat Med. 2004;18:525–542.
doi: 10.1191/0269216304pm921oa
Woods A, Willison K, Kington C, et al. Palliative care for people with severe persistent mental illness: a review of the literature. Can J Psychiatry. 2008;53:725–736.
doi: 10.1177/070674370805301104
O’Hanlon C, Huang C, Sloss E, et al. Comparing VA and non-VA quality of care: a systematic review. J Gen Intern Med. 2017;32:105–121.
doi: 10.1007/s11606-016-3775-2